Finally, integrating additional multi-omics approaches, such as proteomics and metabolomics, could provide a more comprehensive understanding of the complex regulatory roles of MDK-NCL signaling in tumor progression and immune evasion. This evidence concerns the gene NUCLEOLIN and neoplasm.